During the past decade, Pius-Hospital; Klinik fuer Haematologie und Onkologie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pius-Hospital; Klinik fuer Haematologie und Onkologie" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Pius-Hospital; Klinik fuer Haematologie und Onkologie" are "Non-small Cell Lung Cancer" (3 trials), "Adenocarcinoma" (2 trials), "Carcinoma" (2 trials), "Carcinoma, Bronchogenic" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Pius-Hospital; Klinik fuer Haematologie und Onkologie" in a lesser frequency.

Most popular intervention types in "Pius-Hospital; Klinik fuer Haematologie und Onkologie" are "Drug" (9 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pemetrexed" (4 trials), "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pius-Hospital; Klinik fuer Haematologie und Onkologie" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Pius-Hospital; Klinik fuer Haematologie und Onkologie". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Pius-Hospital; Klinik fuer Haematologie und Onkologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pius-Hospital; Klinik fuer Haematologie und Onkologie, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".